Related Experiment Videos
Incrusted cystitis after intravesical mitomycin C treatment
Summary
Bladder wall calcification is a rare complication of superficial bladder cancer treatment with Mitomycin C. This case report discusses the pathogenic mechanism of this adverse event.
Area of Science:
- Urology
- Oncology
Background:
- Superficial bladder cancer is commonly treated with intravesical therapies.
- Mitomycin C is a frequently used intravesical chemotherapeutic agent.
Observation:
- Bladder wall calcification is an uncommon adverse event associated with intravesical Mitomycin C therapy.
- Literature review identified only two previously reported cases.
Findings:
- This report details a new case of bladder wall calcification following intravesical Mitomycin C treatment.
- The pathogenic mechanism underlying this complication is discussed.
Implications:
- Understanding the mechanism of bladder calcification can inform treatment strategies.
- This highlights the importance of monitoring for rare complications in intravesical therapy.